Livtencity 200 mg, Filmtabletten

7680684920011 CH-68492 Filmtabletten
Livtencity 200 mg, Filmtabletten
Livtencity 200 mg, Filmtabletten
Livtencity 200 mg, Filmtabletten
1 / 3
google

Article details

Package size
28
Selling units
28
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
07/02/2026
Patient information leaflet
Français
07/02/2026
Patient information leaflet
Italien
07/02/2026
Summary of Product Characteristics
Allemand
07/02/2026
Summary of Product Characteristics
Français
07/02/2026
Summary of Product Characteristics
Italien
07/02/2026

Detailed composition

Substance Quantity Type Category
maribavirum
200.0 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
carboxymethylamylum natricum A
- Substance HNIDK
magnesii stearas
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
macrogolum 3350
- Substance HNIDK
E 171
- Substance FNIDK
talcum
- Substance HNIDK
E 133
- Substance FIMDK
natrium
- Substance HBESI

Reimbursement information

Public price
CHF 5756.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2024

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
68492
Drug name
Livtencity, Filmtabletten
Galenic form
FILM
ATC Code
J05AX10
Authorization status
Z
Dispensing category
A
First authorization
19/07/2023
Authorization expiration date
18/07/2028
IT Number
08.03.0.
Domain
Human medicine
Field of application
CMV Infektion

Package details

Description (FR)
LIVTENCITY cpr pell 200 mg fl 28 pce
Description (DE)
LIVTENCITY Filmtabl 200 mg Fl 28 Stk
Market launch
19/07/2023
Narcotic (BTM)
No

Other package sizes (1)

LIVTENCITY cpr pell 200 mg fl 56 pce
56 TABL
GTIN: 7680684920028
View
Buy us a coffee Explore the data